Forecast & Rating3 analysts currently cover Mesoblast, of which 3 give a positive rating. The average price target is $35.00, about 110.0% upside from the current price of $16.67. Coverage is limited, so the data is for reference only. Data as of Jul 14, 2026; this does not constitute investment advice.
Jul 14, 2026Price forecast
$35.00109.96%
Forecast & RatingBuy
3analysts
- Strong buy33.33%
- Buy66.67%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met20.8%
Stock price$16.67
Avg. target$35.0
High target$35
Low target$35
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.